Cargando…
From acute SARS-CoV-2 infection to pulmonary hypertension
As the world progressively recovers from the acute stages of the coronavirus disease 2019 (COVID-19) pandemic, we may be facing new challenges regarding the long-term consequences of COVID-19. Accumulating evidence suggests that pulmonary vascular thickening may be specifically associated with COVID...
Autores principales: | Eroume À Egom, Emmanuel, Shiwani, Haaris A., Nouthe, Brice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806360/ https://www.ncbi.nlm.nih.gov/pubmed/36601347 http://dx.doi.org/10.3389/fphys.2022.1023758 |
Ejemplares similares
-
Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Egom, Emmanuel Eroume A.
Publicado: (2021) -
Pulmonary Arterial Hypertension Due to NPR-C Mutation: A Novel Paradigm for Normal and Pathologic Remodeling?
por: Egom, Emmanuel Eroume-A
Publicado: (2019) -
Role of natriuretic peptide receptor C signalling in obesity-induced
heart failure with preserved ejection fraction with pulmonary
hypertension
por: Eroume-A Egom, Emmanuel, et al.
Publicado: (2020) -
COVID-19 and myocarditis: a review of literature
por: Ali, Mohammed, et al.
Publicado: (2022) -
Identifying Potential Mutations Responsible for Cases of Pulmonary Arterial Hypertension
por: Egom, Emmanuel Eroume-A, et al.
Publicado: (2021)